Medications that inhibit interleukin-1beta (IL-1beta), which is a molecule that simulates the immune system, is given to rheumatoid arthritis patients. These patients are more likely to experience invasive Group A Streptococcal infections than patients not on the drug, according to University of California San Diego School of Medicine researchers. It also uncovers a critical […]
